Published in Nature on July 08, 2004
Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature (2009) 11.34
Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A (2006) 9.26
The viral polymerase mediates adaptation of an avian influenza virus to a mammalian host. Proc Natl Acad Sci U S A (2005) 7.39
Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12
Evolution of H5N1 avian influenza viruses in Asia. Emerg Infect Dis (2005) 6.99
Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev (2007) 6.38
Avian influenza H5N1 in tigers and leopards. Emerg Infect Dis (2004) 6.16
The polymerase complex genes contribute to the high virulence of the human H5N1 influenza virus isolate A/Vietnam/1203/04. J Exp Med (2006) 5.94
Insights into the interaction between influenza virus and pneumococcus. Clin Microbiol Rev (2006) 5.92
Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78
Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol (2005) 5.48
Lethality to ferrets of H5N1 influenza viruses isolated from humans and poultry in 2004. J Virol (2005) 5.40
Human infection with an avian H9N2 influenza A virus in Hong Kong in 2003. J Clin Microbiol (2005) 5.04
Free-grazing ducks and highly pathogenic avian influenza, Thailand. Emerg Infect Dis (2006) 4.55
Emergence and predominance of an H5N1 influenza variant in China. Proc Natl Acad Sci U S A (2006) 4.49
Proinflammatory cytokine responses induced by influenza A (H5N1) viruses in primary human alveolar and bronchial epithelial cells. Respir Res (2005) 4.41
Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals. J Clin Invest (2008) 4.30
Mapping H5N1 highly pathogenic avian influenza risk in Southeast Asia. Proc Natl Acad Sci U S A (2008) 3.70
Prophylactic and therapeutic efficacy of human monoclonal antibodies against H5N1 influenza. PLoS Med (2007) 3.63
Genome analysis linking recent European and African influenza (H5N1) viruses. Emerg Infect Dis (2007) 3.53
H5N1 outbreaks and enzootic influenza. Emerg Infect Dis (2006) 3.49
Identification of a novel coronavirus in bats. J Virol (2005) 3.48
Wild ducks as long-distance vectors of highly pathogenic avian influenza virus (H5N1). Emerg Infect Dis (2008) 3.37
Susceptibility of North American ducks and gulls to H5N1 highly pathogenic avian influenza viruses. Emerg Infect Dis (2006) 3.36
Host range restriction and pathogenicity in the context of influenza pandemic. Emerg Infect Dis (2006) 3.27
Highly pathogenic avian influenza H5N1, Thailand, 2004. Emerg Infect Dis (2005) 3.26
Influenza A H5N1 replication sites in humans. Emerg Infect Dis (2005) 3.21
The genesis and evolution of H9N2 influenza viruses in poultry from southern China, 2000 to 2005. J Virol (2007) 3.12
Domestic ducks and H5N1 influenza epidemic, Thailand. Emerg Infect Dis (2006) 2.98
Characterization of highly pathogenic H5N1 avian influenza A viruses isolated from South Korea. J Virol (2005) 2.97
Mallards and highly pathogenic avian influenza ancestral viruses, northern Europe. Emerg Infect Dis (2005) 2.90
Pandemic flu: we are not prepared. MedGenMed (2005) 2.89
Influenza A virus (H5N1) infection in cats causes systemic disease with potential novel routes of virus spread within and between hosts. Am J Pathol (2006) 2.77
Live attenuated influenza viruses containing NS1 truncations as vaccine candidates against H5N1 highly pathogenic avian influenza. J Virol (2008) 2.71
Avian influenza, domestic ducks and rice agriculture in Thailand. Agric Ecosyst Environ (2007) 2.64
Studies of H5N1 influenza virus infection of pigs by using viruses isolated in Vietnam and Thailand in 2004. J Virol (2005) 2.56
Food markets with live birds as source of avian influenza. Emerg Infect Dis (2006) 2.55
Mitigation measures for pandemic influenza in Italy: an individual based model considering different scenarios. PLoS One (2008) 2.54
Fatal avian influenza A H5N1 in a dog. Emerg Infect Dis (2006) 2.53
Vaccines and antiviral drugs in pandemic preparedness. Emerg Infect Dis (2006) 2.52
Isolation and characterization of avian influenza viruses, including highly pathogenic H5N1, from poultry in live bird markets in Hanoi, Vietnam, in 2001. J Virol (2005) 2.51
Risk factors for human illness with avian influenza A (H5N1) virus infection in China. J Infect Dis (2009) 2.50
The influenza virus enigma. Cell (2009) 2.48
Evolution and molecular epidemiology of H9N2 influenza A viruses from quail in southern China, 2000 to 2005. J Virol (2006) 2.47
Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization. J Virol (2006) 2.47
Novel reassortant highly pathogenic H5N2 avian influenza viruses in poultry in China. PLoS One (2012) 2.43
Anatidae migration in the western Palearctic and spread of highly pathogenic avian influenza H5NI virus. Emerg Infect Dis (2006) 2.40
Environmental transmission of low pathogenicity avian influenza viruses and its implications for pathogen invasion. Proc Natl Acad Sci U S A (2009) 2.38
Highly pathogenic H5N1 influenza virus in smuggled Thai eagles, Belgium. Emerg Infect Dis (2005) 2.37
Pathology, molecular biology, and pathogenesis of avian influenza A (H5N1) infection in humans. Am J Pathol (2008) 2.36
High level of genetic compatibility between swine-origin H1N1 and highly pathogenic avian H5N1 influenza viruses. J Virol (2010) 2.29
Global surveillance of emerging Influenza virus genotypes by mass spectrometry. PLoS One (2007) 2.29
Establishment of influenza A virus (H6N1) in minor poultry species in southern China. J Virol (2007) 2.26
Differences in cytokine production in human macrophages and in virulence in mice are attributable to the acidic polymerase protein of highly pathogenic influenza A virus subtype H5N1. J Infect Dis (2012) 2.24
Poultry-handling practices during avian influenza outbreak, Thailand. Emerg Infect Dis (2005) 2.20
Susceptibilities of antiviral-resistant influenza viruses to novel neuraminidase inhibitors. Antimicrob Agents Chemother (2005) 2.17
Passive immunoprophylaxis and therapy with humanized monoclonal antibody specific for influenza A H5 hemagglutinin in mice. Respir Res (2006) 2.15
Influenza Virus Database (IVDB): an integrated information resource and analysis platform for influenza virus research. Nucleic Acids Res (2006) 2.14
Avian influenza H5N1 in naturally infected domestic cat. Emerg Infect Dis (2006) 2.14
Evolutionary dynamics and emergence of panzootic H5N1 influenza viruses. PLoS Pathog (2008) 2.14
Environmental factors contributing to the spread of H5N1 avian influenza in mainland China. PLoS One (2008) 2.14
Role of specific hemagglutinin amino acids in the immunogenicity and protection of H5N1 influenza virus vaccines. Proc Natl Acad Sci U S A (2005) 2.13
Comparative analysis of complete genome sequences of three avian coronaviruses reveals a novel group 3c coronavirus. J Virol (2008) 2.06
The development and genetic diversity of H5N1 influenza virus in China, 1996-2006. Virology (2008) 2.04
Efficacy of oseltamivir therapy in ferrets inoculated with different clades of H5N1 influenza virus. Antimicrob Agents Chemother (2007) 2.03
Spatial distribution and risk factors of highly pathogenic avian influenza (HPAI) H5N1 in China. PLoS Pathog (2011) 2.02
A sensitive retroviral pseudotype assay for influenza H5N1-neutralizing antibodies. Influenza Other Respir Viruses (2007) 1.92
Evolution of highly pathogenic H5N1 avian influenza viruses in Vietnam between 2001 and 2007. PLoS One (2008) 1.91
Comparative analysis of 22 coronavirus HKU1 genomes reveals a novel genotype and evidence of natural recombination in coronavirus HKU1. J Virol (2006) 1.87
Characterization of low-pathogenic H5 subtype influenza viruses from Eurasia: implications for the origin of highly pathogenic H5N1 viruses. J Virol (2007) 1.86
Current and future antiviral therapy of severe seasonal and avian influenza. Antiviral Res (2008) 1.86
Quantification of the effect of vaccination on transmission of avian influenza (H7N7) in chickens. Proc Natl Acad Sci U S A (2005) 1.86
Indications that live poultry markets are a major source of human H5N1 influenza virus infection in China. J Virol (2011) 1.85
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivir. Antimicrob Agents Chemother (2006) 1.85
Risk for infection with highly pathogenic influenza A virus (H5N1) in chickens, Hong Kong, 2002. Emerg Infect Dis (2007) 1.79
Identification of the progenitors of Indonesian and Vietnamese avian influenza A (H5N1) viruses from southern China. J Virol (2008) 1.78
X-ray structure of NS1 from a highly pathogenic H5N1 influenza virus. Nature (2008) 1.77
H5N1 influenza viruses: outbreaks and biological properties. Cell Res (2009) 1.72
Generation and characterization of recombinant influenza A (H1N1) viruses harboring amantadine resistance mutations. Antimicrob Agents Chemother (2005) 1.72
Influenza A (H5N1) viruses from pigs, Indonesia. Emerg Infect Dis (2010) 1.70
Establishment of an H6N2 influenza virus lineage in domestic ducks in southern China. J Virol (2010) 1.69
Domestic pigs have low susceptibility to H5N1 highly pathogenic avian influenza viruses. PLoS Pathog (2008) 1.66
Antigenic profile of avian H5N1 viruses in Asia from 2002 to 2007. J Virol (2007) 1.65
H5N1 influenza viruses in Lao People's Democratic Republic. Emerg Infect Dis (2006) 1.64
New genotype of avian influenza H5N1 viruses isolated from tree sparrows in China. J Virol (2005) 1.64
Evidence of expanded host range and mammalian-associated genetic changes in a duck H9N2 influenza virus following adaptation in quail and chickens. PLoS One (2008) 1.63
Characterization of avian influenza viruses A (H5N1) from wild birds, Hong Kong, 2004-2008. Emerg Infect Dis (2009) 1.61
A consensus-hemagglutinin-based DNA vaccine that protects mice against divergent H5N1 influenza viruses. Proc Natl Acad Sci U S A (2008) 1.59
Reassortment between avian H5N1 and human H3N2 influenza viruses creates hybrid viruses with substantial virulence. Proc Natl Acad Sci U S A (2010) 1.56
The special neuraminidase stalk-motif responsible for increased virulence and pathogenesis of H5N1 influenza A virus. PLoS One (2009) 1.55
Emergence of H5N1 avian influenza viruses with reduced sensitivity to neuraminidase inhibitors and novel reassortants in Lao People's Democratic Republic. J Gen Virol (2009) 1.52
The conformation of the pore region of the M2 proton channel depends on lipid bilayer environment. Protein Sci (2005) 1.52
Pandemic influenza planning in the United States from a health disparities perspective. Emerg Infect Dis (2008) 1.51
Hemagglutinin-pseudotyped green fluorescent protein-expressing influenza viruses for the detection of influenza virus neutralizing antibodies. J Virol (2009) 1.50
Real time bayesian estimation of the epidemic potential of emerging infectious diseases. PLoS One (2008) 1.46
Reassortant avian influenza virus (H5N1) in poultry, Nigeria, 2007. Emerg Infect Dis (2008) 1.46
Influenza A H5N1 immigration is filtered out at some international borders. PLoS One (2008) 1.46
The great opportunity: Evolutionary applications to medicine and public health. Evol Appl (2008) 1.43
Wildlife as source of zoonotic infections. Emerg Infect Dis (2004) 1.42
Initial sequencing and analysis of the human genome. Nature (2001) 212.86
The sequence of the human genome. Science (2001) 101.55
The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics (2003) 32.92
Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet (2003) 24.78
Universal primer set for the full-length amplification of all influenza A viruses. Arch Virol (2001) 21.17
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature (1996) 16.92
Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus. Lancet (1998) 16.30
Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12. Immunity (2000) 16.03
To What Degree Are Mortality Statistics Dependable? Am J Public Health Nations Health (1940) 15.65
Crystal structure at 3.5 A resolution of HIV-1 reverse transcriptase complexed with an inhibitor. Science (1992) 14.70
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet (2003) 13.79
Inactivation of the type II TGF-beta receptor in colon cancer cells with microsatellite instability. Science (1995) 13.15
Clinical features and rapid viral diagnosis of human disease associated with avian influenza A H5N1 virus. Lancet (1998) 12.89
Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. Science (2003) 12.59
A DNA transfection system for generation of influenza A virus from eight plasmids. Proc Natl Acad Sci U S A (2000) 12.16
Influenzavirus neuraminidase and neuraminidase-inhibition test procedures. Bull World Health Organ (1973) 10.70
Avian-to-human transmission of the PB1 gene of influenza A viruses in the 1957 and 1968 pandemics. J Virol (1989) 10.63
Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med (2001) 10.36
Avian flu: H5N1 virus outbreak in migratory waterfowl. Nature (2005) 10.04
Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S. Diabetes Care (2001) 9.76
Human infection with influenza H9N2. Lancet (1999) 9.73
Highly pathogenic H5N1 influenza virus infection in migratory birds. Science (2005) 9.64
Re-emergence of fatal human influenza A subtype H5N1 disease. Lancet (2004) 9.36
Establishment of multiple sublineages of H5N1 influenza virus in Asia: implications for pandemic control. Proc Natl Acad Sci U S A (2006) 9.26
Disquisitions of Original Antigenic Sin. I. Evidence in man. J Exp Med (1966) 9.26
Induction of proinflammatory cytokines in human macrophages by influenza A (H5N1) viruses: a mechanism for the unusual severity of human disease? Lancet (2002) 8.70
A pandemic warning? Nature (1997) 8.70
Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong? Proc Natl Acad Sci U S A (1999) 8.62
Molecular basis for the generation in pigs of influenza A viruses with pandemic potential. J Virol (1998) 8.44
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest (1999) 8.38
Identification of a gene that causes primary open angle glaucoma. Science (1997) 8.14
Receptor specificity in human, avian, and equine H2 and H3 influenza virus isolates. Virology (1994) 8.06
Characterization of avian H5N1 influenza viruses from poultry in Hong Kong. Virology (1998) 7.99
Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders. Cancer Res (1997) 7.95
Mitochondrial transcription factor A is necessary for mtDNA maintenance and embryogenesis in mice. Nat Genet (1998) 7.89
Genetic reassortment of avian, swine, and human influenza A viruses in American pigs. J Virol (1999) 7.72
Assessment of client/patient satisfaction: development of a general scale. Eval Program Plann (1979) 7.45
Intestinal influenza: replication and characterization of influenza viruses in ducks. Virology (1978) 7.35
Role of domestic ducks in the propagation and biological evolution of highly pathogenic H5N1 influenza viruses in Asia. Proc Natl Acad Sci U S A (2005) 7.12
Involvement of the TIP60 histone acetylase complex in DNA repair and apoptosis. Cell (2000) 6.70
H5N1 influenza: a protean pandemic threat. Proc Natl Acad Sci U S A (2004) 6.61
Cocirculation of avian H9N2 and contemporary "human" H3N2 influenza A viruses in pigs in southeastern China: potential for genetic reassortment? J Virol (2001) 6.45
Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus. J Immunol (1967) 6.41
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23
Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR. Proc Natl Acad Sci U S A (2002) 6.17
A global profile of germline gene expression in C. elegans. Mol Cell (2000) 5.97
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci U S A (1995) 5.92
Requirement for neuregulin receptor erbB2 in neural and cardiac development. Nature (1995) 5.91
The evolution of H5N1 influenza viruses in ducks in southern China. Proc Natl Acad Sci U S A (2004) 5.87
Are ducks contributing to the endemicity of highly pathogenic H5N1 influenza virus in Asia? J Virol (2005) 5.78